Travoprost

A summary of the most common chemical descriptors (InChI Key and SMILES codes) for Travoprost are summarized together with 3D and 2D structures and relevant physico-chemical properties.

What is the Travoprost?

The molecule Travoprost presents a molecular formula of C26H35F3O6 and its IUPAC name is propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]hept-5-enoate.

Travoprost is a synthetic prostaglandin analog used as a topical ophthalmic solution to treat glaucoma and ocular hypertension. It is a prodrug of travoprost acid, which is a selective agonist of the prostaglandin F2-alpha receptor. Travoprost is marketed by Alcon under the brand name Travatan..

Travoprost was approved by the United States Food and Drug Administration (FDA) in December 2001. In Europe, it was first approved in Sweden in June 2002. Travoprost is also approved in Canada, Brazil, and several other countries..

The most common side effects of travoprost are itching and redness of the eyes. Other rare side effects include changes in eyelash appearance, darkening of the iris, and growth of facial hair..

Travoprost is a prodrug of travoprost acid, which is a selective agonist of the prostaglandin F2-alpha receptor. The exact mechanism of action of travoprost is not known, but it is thought to lower intraocular pressure by increasing the outflow of aqueous humor..

Travoprost is a white powder that is soluble in organic solvents. It is formulated as a 0.004% solution for topical ophthalmic use..

Travoprost is typically used once daily in the evening. The recommended dosage is one drop in each eye..

Travoprost should be used with caution in patients with a history of hypersensitivity to prostaglandins. The most common side effects of travoprost are itching and redness of the eyes. Other rare side effects include changes in eyelash appearance, darkening of the iris, and growth of facial hair..

Travoprost is a safe and effective medication for the treatment of glaucoma and ocular hypertension. It is well tolerated with a low incidence of side effects..

3D structure

Cartesian coordinates

Geometry of Travoprost in x, y and z coordinates (Å units) to copy/paste elsewhere. Generated with Open Babel software.

2D drawing

 

Travoprost MKPLKVHSHYCHOC-AHTXBMBWSA-N chemical compound 2D structure molecule svg
Travoprost

 

Molecule descriptors

 
IUPAC namepropan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]hept-5-enoate
InChI codeInChI=1S/C26H35F3O6/c1-17(2)35-25(33)11-6-4-3-5-10-21-22(24(32)15-23(21)31)13-12-19(30)16-34-20-9-7-8-18(14-20)26(27,28)29/h3,5,7-9,12-14,17,19,21-24,30-32H,4,6,10-11,15-16H2,1-2H3/b5-3-,13-12+/t19-,21-,22-,23+,24-/m1/s1
InChI KeyMKPLKVHSHYCHOC-AHTXBMBWSA-N
SMILESCC(C)OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)COc1cccc(C(F)(F)F)c1

Other names (synonyms)

IUPAC nomenclature provides a standardized method for naming chemical compounds. Although this system is widely used in chemistry, many chemical compounds have also other names commonly used in different contexts. These synonyms can come from a variety of sources and are used for a variety of purposes.

One common source of synonyms for chemical compounds is the common or trivial names, assigned on the basis of appearance, properties, or origin of the molecule.

Another source of synonyms are historical or obsolete names employed in the past, however replaced nowadays by more modern or standardized names.

In addition to common and historical names, chemical compounds may also have synonyms that are specific to a particular field or industry.

  • (((1R)-(1alpha(Z),2beta(1E,3R*),3alpha,5alpha))-7-(3,5-dihydroxy-2-(3-hydroxy-4-(3-trifluoromethyl)phenoxy)-1-butenyl)cyclopentyl)-5-heptenoic acid, 1-methylethyl ester
  • (+)-Fluprostenol isopropyl ester
  • (1R-(1.ALPHA.(Z),2.BETA.(1E,3R*),3.ALPHA.,5.ALPHA.))-7-(3,5-DIHYDROXY-2-(3-HYDROXY-4-(3-(TRIFLUOROMETHYL)PHENOXY)-1-BUTENYL)CYCLOPENTYL)-5-HEPTENOIC ACID, 1-METHYLETHYL ESTER
  • (1R-(1alpha(Z),2beta(1E,3R*),3alpha,5alpha))-7-(3,5-Dihydroxy-2-(3-hydroxy-4-(3-(trifluoromethyl)phenoxy)-1-butenyl)cyclopentyl)-5-heptenoic acid, 1-methylethyl ester
  • (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]cyclopentyl]-5-heptenoic acid 1-methyethyl ester
  • (Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1E,3R)-3-hydroxy-4-((alpha,alpha,alpha-trifluoro-m-isopropyl-tolyl)oxy)-1-butenyl)cyclopentyl)-5-heptenoate
  • (Z)-isopropyl 7-((1R,2R)-3,5-dihydroxy-2-((S,E)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)cyclopentyl)hept-5-enoate
  • (Z)-isopropyl 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,E)-3-hydroxy-4-(3-(trifluoromethyl) phenoxy)but-1-en-1-yl)cyclopentyl)hept-5-enoate
  • (Z)-isopropyl 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,E)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)cyclopentyl)hept-5-enoate
  • (Z)-isopropyl7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,E)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)cyclopentyl)hept-5-enoate
  • 157283-68-6
  • 283T686
  • 5-Heptenoic acid, 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3R)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)-1-butenyl)cyclopentyl)-, 1-methylethyl ester, (5Z)-
  • 5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-4-(3-(trifluoromethyl)phenoxy)-1-butenyl)cyclopentyl)-, 1-methylethyl ester, (1R-(1alpha(Z),2beta(1E,3R*),3alpha,5alpha))-
  • 5-Heptenoic acid, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]cyclopentyl]-, 1-methylethyl ester, (5Z)-
  • AC-6103
  • AL-6221
  • AL6221
  • AM84515
  • BDBM50248302
  • BS-15509
  • CCG-269692
  • D01964
  • DB00287
  • DUOTRAV COMPONENT TRAVOPROST
  • EX-A1772
  • Fluprostenol isopropyl ester;AL6221;Flu-Ipr
  • GTPL7102
  • HY-B0584
  • ISOPROPYL (Z)-7-((1R,2R,3R,5S)-3,5-DIHYDROXY-2-((1E,3R)-3-HYDROXY-4-((.ALPHA.,.ALPHA.,.ALPHA.-TRIFLUORO-M-TOLYL)OXY)-1-BUTENYL)CYCLOPENTYL)-5-HEPTENOATE
  • Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R,E)-3-hydroxy-4-(3-(trifluoromethyl)-phenoxy)-but-1-enyl)-cyclopentyl)-hept-5-enoate
  • Izba
  • J-502633
  • NCGC00346741-02
  • NSC 760366
  • NSC-760366
  • Otx-tp
  • Q2193376
  • SR-01000942266
  • SR-01000942266-1
  • SR-01000946860
  • SR-01000946860-1
  • TRAVOPROST COMPONENT OF DUOTRAV
  • Travaprost
  • Travatan
  • Travatan Z
  • Travatanz
  • Travoprost
  • Travoprost (JAN/USP/INN)
  • Travoprost in bulk
  • Travoprostintermediates
  • Trovoprost
  • WJ68R08KX9
  • isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1E,3R)-3-hydroxy-4-[(alpha,alpha,alpha-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate
  • propan-2-yl (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-en-1-yl]cyclopentyl]hept-5-enoate
  • propan-2-yl (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-{(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-en-1-yl}cyclopentyl]hept-5-enoate
  • propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]hept-5-enoate
  • s3738
  • travoprostum

Reference codes for other databases

There exist several different chemical codes commonly used in orded to identify molecules:
  • ZINC4474682
  • UNII-WJ68R08KX9
  • AKOS024458039
  • DTXSID80896948
  • CHEMBL1200799
  • CHEBI:746859
  • SCHEMBL93818

Physico-Chemical properties

IUPAC namepropan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]hept-5-enoate
Molecular formulaC26H35F3O6
Molecular weight500.548
Melting point (ºC)
Boiling point (ºC)
Density (g/cm3)
Molar refractivity126.17
LogP4.4
Topological polar surface area96.2

LogP and topological polar surface area (TPSA) values were estimated using Open Babel software.

The n-octanol/water partition coeficient (Kow) data is applied in toxicology and drug research. Kow values are used, to guess the environmental fate of persistent organic pollutants. High partition coefficients values, tend to accumulate in the fatty tissue of organisms. Molecules with a log(Kow) (or LogP) greater than 5 are considered to bioaccumulate.

TPSA values are the sum of the surface area over all polar atoms or molecules, mainly oxygen and nitrogen, also including hydrogen atoms.

In medicinal chemistry, TPSA is used to assess the ability of a drug to permeabilise cells.

For molecules to penetrate the blood-brain barrier (and act on receptors in the central nervous system), TPSA values below 90 Å2 are required. Thus, molecules with a polar surface area greater than 140 Å2 tend to be poorly permeable to cell membranes.